Background: The benefit of intravenous thrombolysis (IVT) before mechanical thrombectomy (MT) in patients with large vessel occlusion (LVO) stroke is uncertain. Conventional metrics of final modified thrombolysis in cerebral ischemia (mTICI) score and 90-d modified Rankin Scale may be insensitive to IVT effects on procedural complexity and duration.
Objective: To study the effect of IVT prior to MT on clot survival.
Methods: We performed a single-center retrospective analysis of 257 acute stroke patients with LVO undergoing MT and analyzed the effect of IVT prior to MT using a novel, pass-by-pass clot survival methodology.
Results: The use of IVT was associated with a significantly lower number of passes to attain mTICI 2B or greater (P = .002) or mTICI 3 (P = .039) reperfusion. The number of patients who achieved mTICI 2B or greater after the first pass was significantly higher in the IVT group (P = .003). This increased rate of reperfusion persisted into subsequent passes.
Conclusion: IVT prior to MT reduces the number of thrombectomy passes required to achieve mTICI 2B or mTICI 3 reperfusion. This information should be considered as the merits of IVT prior to MT are debated.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/neuros/nyab344 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intravitreal Administration of Avacincaptad Pegol in a Nonhuman Primate Model of Dry Age-Related Macular Degeneration.
Pharmacol Res Perspect
February 2025
Hamamatsu Pharma Research, Inc., Hamamatsu, Shizuoka, Japan.
The lack of effective treatments for dry age-related macular degeneration (AMD) is in part due to a lack of a preclinical animal model that recapitulates features of the clinical state including macular retinal pigment epithelium (RPE) degeneration, also known as geographic atrophy (GA). A nonhuman primate model of GA was developed and its responsiveness to an approved treatment, avacincaptad pegol (ACP), a complement C5 inhibitor, was evaluated. Intravitreal (ivt) administration of sodium iodate (SI) into one eye of male Macaca fascicularis leads to retinal areas (mm) of hyper- or hypo-autofluorescence.
View Article and Find Full Text PDF2-year results from an observational study of proactive treatment regimens with intravitreal aflibercept 2 mg in patients with nAMD in clinical practice: XTEND study UK cohort.
Eye (Lond)
December 2024
Department of Ophthalmology, Sunderland Eye Infirmary, South Tyneside & Sunderland NHS Foundation Trust, Sunderland, UK.
Objectives: The 36-month XTEND (NCT03939767) multicentre, observational, prospective study examined the effectiveness of proactive treatment regimens of intravitreal aflibercept (IVT-AFL) 2 mg in treatment-naïve patients with neovascular age-related macular degeneration (nAMD) in routine clinical practice. The 12- and 24-month outcomes from the XTEND UK cohort are reported.
Methods: Patients aged ≥50 years with nAMD planned to receive IVT-AFL 2 mg were eligible.
Direct endovascular treatment may be more appropriate for patients with good collateral circulation: a retrospective case-control study.
Quant Imaging Med Surg
December 2024
Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Article Synopsis
- Recent studies indicate that endovascular treatment (EVT) alone is as effective as combining intravenous thrombolysis with EVT (IVT + EVT) for treating acute ischemic stroke due to large-vessel occlusion, although some research suggests specific patient subgroups may benefit more from IVT.
- This study analyzed data from 238 patients who underwent EVT or IVT + EVT to determine how collateral circulation affects clinical outcomes, using various statistical methods to control for factors like age and stroke severity.
- Findings revealed that patients with good collateral circulation had significantly better outcomes at 90 days, including lower disability scores, higher success rates of recanalization, and reduced rates of complications such as hemorrhage and mortality.
Thrombectomy Failure and Associated Factors for Large-vessel Occlusion Stroke.
Curr Neurovasc Res
November 2024
Neurointervention Division, Mahar Mardjono National Brain Center Hospital, East Jakarta, Indonesia.
Background: Ischemic stroke due to Large Vessel Occlusion (LVO) represents a critical and time-sensitive neurological emergency. Advancements in imaging technology and endovascular therapies have transformed the management of LVO. Nonetheless, thrombectomy failure diminishes the chances of patients achieving a favorable clinical outcome.
View Article and Find Full Text PDFBridging the Gap: Improving Acute Ischemic Stroke Outcomes with Intravenous Thrombolysis Prior to Mechanical Thrombectomy.
Neurol Int
October 2024
Stroke Unit, Department of Neurology, University of Pécs, 7624 Pécs, Hungary.
Background/objectives: Current guidelines recommend intravenous thrombolysis (IVT) followed by mechanical thrombectomy (MT) for patients with acute ischemic stroke (AIS) caused by large vessel occlusion (LVO). This combined approach, known as bridging therapy (BT), is believed to increase the likelihood of a favorable functional outcome when administered within 4.5 h of symptom onset.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!